BridgeMD
New treatment option for Attention Deficit Hyperactivity Disorder (ADHD)
Official title Deficit Hyperactivity Disorder / Substance Use Disorder Comorbidity in Integrated Treatment
ClinicalTrials.gov ID: NCT06858527
What this study is testing
- What it's testing
- Attention Deficit Hyperactivity Disorder (ADHD) and Substance Use Disorders (SUDs) is a highly common comorbid condition associated with serious medical and psychosocial consequences. However, and despite the international consensus recommending integrated treatment for this comorbidity, few studies tested the efficacy of specific psychotherapeutic treatment for this comorbidity.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age 18 or older ;
- Suffer from at least one moderate to severe SUD regarding the DSM-5 (tobacco excluded) ;
- Being currently treated for a SUD by a physician of a psychologist ;
- Being diagnosed with an ADHD according to the DIVA 2.0 of DIVA-5 ;
- Being affiliated to a health insurance ;
You likely can't join if
- Age under 18;
- Pregnant or breastfeeding women;
- Not having sign the consent form;
- Major difficulties in understanding and/or expressing themselves in french;
- Severe cognitive impairment;
- Acute medical condition making assessment impossible and/or contraindicating participation in group intervention;
See the full eligibility criteria
- Age 18 or older ;
- Suffer from at least one moderate to severe SUD regarding the DSM-5 (tobacco excluded) ;
- Being currently treated for a SUD by a physician of a psychologist ;
- Being diagnosed with an ADHD according to the DIVA 2.0 of DIVA-5 ;
- Being affiliated to a health insurance ;
- Understanding and being able to express himselves in French
- Signed consent
- Age under 18;
- Pregnant or breastfeeding women;
- Not having sign the consent form;
- Major difficulties in understanding and/or expressing themselves in french;
- Severe cognitive impairment;
- Acute medical condition making assessment impossible and/or contraindicating participation in group intervention;
- Substance use disorder in a protected environment, currentlu or in the last 15 days, or expected during the study;
- No substance use disorder other than tobacco use disorder;
- Persons under guardianship;
- Participant deprived of liberty or under penal care orders;
- Participation in another group psychotherapeutic intervention throughout the duration of the intervention
The study team makes the final eligibility decision.
Where it's taking place
- Paris, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.